Home/Filings/4/0000875320-25-000240
4//SEC Filing

Biller Jonathan 4

Accession 0000875320-25-000240

CIK 0000875320other

Filed

Dec 4, 7:00 PM ET

Accepted

Dec 5, 4:06 PM ET

Size

4.7 KB

Accession

0000875320-25-000240

Insider Transaction Report

Form 4
Period: 2025-12-03
Biller Jonathan
EVP and Chief Legal Officer
Transactions
  • Sale

    Common Stock

    2025-12-03$449.00/sh347$155,80315,306 total
Footnotes (1)
  • [F1]Transaction made pursuant to Mr. Biller's company approved trading plan under Rule 10b5-1, which was entered into on 02/24/2025.

Issuer

VERTEX PHARMACEUTICALS INC / MA

CIK 0000875320

Entity typeother

Related Parties

1
  • filerCIK 0001744749

Filing Metadata

Form type
4
Filed
Dec 4, 7:00 PM ET
Accepted
Dec 5, 4:06 PM ET
Size
4.7 KB